glp-1 and liver fatty disease. Non-alcoholic fatty liver disease affects 25% of adults worldwide. It is directly linked to excess weight and insulin resistance. Left untreated, it can progress to cirrhosis and 8 Benefits of GLP‑1's Beyond

Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland

Martel et al

Learn how THC and GLP-1 medications may interact and what to consider for appetite, wellness, and your overall experience.

Illinois spent nearly $3.8 billion on state employee healthcare last year, with researchers pointing to rising use of GLP-1 drugs like Ozempic as a possible factor.

is a cofounder of Longevity Biotech, Inc., which is pursuing biomedical applications for a/b-peptides

Conclusions GLP-1RA therapy in patients with CS and associated metabolic disorders led to significant improvements in weight, BMI, and glycemic control without worsening cortisol dynamics or liver function